CYTR - CytRx Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.66
-0.04 (-2.35%)
At close: 4:00PM EDT

1.63 -0.03 (-1.81%)
After hours: 4:46PM EDT

Stock chart is not supported by your current browser
Previous Close1.70
Open1.70
Bid1.57 x 4000
Ask1.84 x 2000
Day's Range1.65 - 1.72
52 Week Range1.43 - 6.00
Volume103,378
Avg. Volume401,038
Market Cap46.542M
Beta1.43
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents26 days ago

    Edited Transcript of CYTR earnings conference call or presentation 19-Mar-18 3:00pm GMT

    Q4 2017 CytRx Corp Earnings Call

  • Associated Presslast month

    CytRx reports 4Q loss

    The Los Angeles-based company said it had a loss of 16 cents per share. The cancer drug developer posted revenue of $100,000 in the period. For the year, the company reported that its loss narrowed to ...

  • Are Earnings Prospects Improving For Loss-Making CytRx Corporation’s (NASDAQ:CYTR)?
    Simply Wall St.2 months ago

    Are Earnings Prospects Improving For Loss-Making CytRx Corporation’s (NASDAQ:CYTR)?

    Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess CytRx Corporation’s (NASDAQ:CYTR) track record on a highRead More...

  • Associated Press5 months ago

    CytRx reports 3Q loss

    On a per-share basis, the Los Angeles-based company said it had a loss of 19 cents. Losses, adjusted for non-recurring gains, were 33 cents per share. The company's shares closed at $1.93. A year ago, ...

  • Is CytRx Corporation’s (CYTR) Balance Sheet A Threat To Its Future?
    Simply Wall St.5 months ago

    Is CytRx Corporation’s (CYTR) Balance Sheet A Threat To Its Future?

    CytRx Corporation (NASDAQ:CYTR) is a small-cap stock with a market capitalization of USD $59.70M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, theyRead More...

  • Associated Press9 months ago

    CytRx reports 2Q loss

    The Los Angeles-based company said it had a loss of 10 cents per share. Losses, adjusted for non-recurring costs, came to 7 cents per share. The company's shares closed at 80 cents. A year ago, they were ...

  • 4 Biotech Stocks to Watch This Quarter
    GuruFocus.com9 months ago

    4 Biotech Stocks to Watch This Quarter

    Biotech could easily continue to grow as long-term trends remain in place

  • Investopedia10 months ago

    Penny Stocks to Watch for June 2017 (CYTR, DELT)

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in 2017.

  • TheStreet.com11 months ago

    Goodbye CytRx, Your Game Is Over

    Hope springs eternal, until it's dashed on the rocks and buried at sea.

  • Investopedia11 months ago

    Penny Stocks to Watch for June 2017

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in June 2017 and the coming months.

  • Benzinga11 months ago

    The Most Notable Abstracts Released Ahead Of ASCO 2017

    The American Society of Clinical Oncology, or ASCO, has scheduled its annual meeting on June 2–6, 2017, at McCormick Place, Chicago. The five-day event has Conquer Cancer Foundation as its lead sponsor. ...

  • Associated Press11 months ago

    CytRx reports 1Q loss

    On a per-share basis, the Los Angeles-based company said it had a loss of 10 cents. The company's shares closed at 46 cents. A year ago, they were trading at $3.07. _____ This story was generated by Automated ...

  • Investopedialast year

    Penny Stocks to Watch for May 2017

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.